BAX - Baxter International Inc.
Barbara Oil Co. purchased a new position in Baxter International Inc. (NYSE: BAX) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 40,000 shares of the medical instruments supplier's stock, valued at approximately $853,000. Several other hedge funds also recently made changes
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced it has appointed John Rogers as executive vice president and chief financial officer (CFO), reporting to Baxter president and chief executive officer (CEO), Andrew Hider, effective Oct. 1, 2026. “John is a proven global finance executive with extensive operational expertise and a successful track record leading complex transformation initiatives,” said Hider. “He is an ideal fit for.
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) (“Baxter” or the “Company”) today announced the pricing terms for its previously announced cash tender offers (each, an “Offer” and collectively, the “Offers”) of the Company's validly tendered (and not validly withdrawn) notes set forth below (the “Notes”) using a “waterfall” methodology under which the Company will accept the Notes in order of their respective acceptance priority levels noted in the table below (the “Accep.
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) (“Baxter” or the “Company”) today announced the early results of its previously announced cash tender offers (each, an “Offer” and collectively, the “Offers”) for its validly tendered (and not validly withdrawn) notes set forth below (collectively, the “Notes”). The Offers are being made pursuant to an Offer to Purchase, dated Aug. 4, 2026 (as it may be amended or supplemented from time to time, the “Offer to Purchase”), whi.
On August 17, 2026, Baxter International Inc (BAX) shares fell 3.1% to a current price of $25.91. This decline comes amid a 52-week price range of $15.73 to $30
On June 30, 2026, Richard Pzena (Trades, Portfolio)'s firm executed a significant addition to its existing position in LKQ Corp (LKQ, Financial), purchasing 9,1
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) (“Baxter” or the “Company”) today announced that it has commenced cash tender offers (each, an “Offer” and collectively, the “Offers”) for the maximum principal amount of validly tendered (and not validly withdrawn) notes set forth below (collectively, the “Notes”), such that the aggregate purchase price, not including accrued and unpaid interest, payable in respect of such Notes will not exceed $500 million. The terms and c.
On August 03, 2026, Baxter International Inc (BAX) shares rose 7.4% today, bringing the current price to $28.10. The stock has shown significant price performan
Baxter International has shown early signs of a turnaround, with improving execution and raised revenue guidance supporting cautious optimism. BAX's valuation has expanded from distressed levels, now trading at ~13x earnings and ~9.5x EV/EBITDA, yet remains attractive if growth continues. Management's focus on operational improvements, cost savings, and a conservative outlook suggests potential for further upside if EPS growth materializes.
It scored double beats on analyst estimates. It also lifted its guidance on both the top and bottom lines.
On July 30, 2026, Baxter International Inc (BAX) shares rose 8.0%, closing at $26.75. This increase comes amidst a volatile 52-week range, with shares oscillati
Baxter beats second-quarter earnings and revenue estimates, posts broad-based segment growth and raises its 2026 outlook despite margin pressure.
Baxter International Inc. (BAX) Q2 2026 Earnings Call Transcript
Baxter International Inc. (NYSE:BAX) stock is trading higher on Thursday after the company reported better-than-expected second-quarter financial results and raised its fiscal 2026 guidance.
The headline numbers for Baxter (BAX) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Baxter International (BAX) came out with quarterly earnings of $0.56 per share, beating the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $0.59 per share a year ago.
Medical products maker Baxter International on Thursday raised its annual profit forecast and beat Wall Street estimates for quarterly results, banking on robust sales of its medical products such as IV solutions.
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the second quarter of 2026. “Our second-quarter results exceeded expectations on both the top and bottom lines, driven by both operating performance and an additional benefit from a tariff refund that was not previously contemplated in our guidance,” said Andrew Hider, president and CEO. “While we're encouraged by this steady progress and core operating momentum, we remain.
Medical product makers face Q2 margin pressure from tariffs and inflation even as demand stays strong. See which earnings reports could surprise.
On July 27, 2026, Baxter International Inc (BAX) shares rose 4.2% today, closing at $23.34. The stock has shown a 52-week range of $15.73 to $29.35, indicating